What Does 99% Peptide Purity Mean?

When a certificate reports 99% purity, that figure usually describes the fraction of a specified component measured by a particular method under stated conditions. It is not an abstract property of the peptide “in general.” It is a test result.

IUPAC defines chemical purity as the mass, amount of substance, or number of entities of a specified component divided by the corresponding measure of the system. The notes to that definition insist that the quantity, the component, and the system must be specified, and that the value is often expressed as a percent.

What the percentage usually measures

On a peptide COA, the percentage is reported according to the method written on the report — often a chromatographic technique. The number answers what that method can observe and how the area or fraction is calculated.

ICH Q2(R2) treats purity as one common purpose of an analytical procedure, alongside assay, identity, and impurities. The purpose of the procedure limits the meaning of the number. A method does not answer every question merely because it produces a percentage.

The figure should therefore be read with the method, the conditions, and, if the report includes them, the acceptance criteria. A field-by-field reading guide is in How to read a peptide certificate of analysis.

What 99% does not automatically mean

A reported 99% purity does not, by itself, support any of these conclusions:

• That 99% of the labeled vial mass is the peptide of interest.
• That the material is sterile.
• That endotoxins are absent, or that they were measured.
• That there is a “correct dose” or a use indication.
• That the material is safe or suitable for human or veterinary use.

Those claims need other data. If the certificate does not contain them, they should not be inferred from the percentage.

Purity, identity, and content

These are distinct attributes. Identity asks whether the material corresponds to the declared entity. Purity asks, within the method, what fraction corresponds to the specified component among what the assay detects. Content or quantity asks how much is present relative to a label or a mass.

In the CGMP framework FDA describes, identity, purity, strength, and quality are not treated as a single test. A manufacturer may accept certain supplier results, but identity is discussed as a specific, separate test. That regulatory detail does not automatically apply to a research peptide; it does illustrate that the attributes do not replace one another.

Sterility and endotoxins

Sterility and endotoxins are microbiological or contaminant questions, not a chemical-purity percentage. A report may include them or not. Many research-peptide certificates document purity and identity above all.

A lot should not be described as endotoxin-free or sterile only because purity is high. If those tests are absent from the report, they are not part of what was documented.

Read the result according to the report’s method

Each result is read according to the methods actually documented. HPLC and LC-MS, for example, do not answer the same question: one is commonly used to characterize components and purity; the other adds mass information that can support identity. That difference is explained in HPLC vs LC-MS in peptide analysis.

Changing the method, column, detector, or calculation can change the number without the material “improving” or “worsening” in an absolute sense. Percentages from different reports should not be compared as if they sat on one universal scale.

How Peptra shows it

On certificate pages, Peptra transcribes purity exactly as it appears in the COA record and labels it reported purity. The value is not rounded. The original document remains the laboratory PDF. The archive is at Verify COA.